|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | (2006.01) |
| C07K 16/36 | (2013.01) | ||
| G01N 33/50 | (2006.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/10 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Patento numeris | 3456744 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18186356.4 |
| Europos patento paraiškos padavimo data | 2014-01-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361754607 P | 2013-01-20 | US |
| (72) |
SEXTON, Daniel, J. , US
FAUCETTE, Ryan , US
KENNISTON, Jon, A. , US
CONLEY, Greg , US
NIXON, Andrew , US
TENHOOR, Christopher , US
ADELMAN, Burt , US
CHYUNG, Yung , US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
| (54) | EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS |
| EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS |